Matches in SemOpenAlex for { <https://semopenalex.org/work/W1970784535> ?p ?o ?g. }
- W1970784535 endingPage "151" @default.
- W1970784535 startingPage "141" @default.
- W1970784535 abstract "The antiproliferative effects of human recombinant interferon-alpha (rIFN-alpha A) and interferon-beta (rIFN-beta ser) were assessed in vitro against seven human glioma cell lines. Further analysis of one of these lines (EFC-2) in response to rIFN-alpha A demonstrated a minimum growth inhibition by day 6 of treatment, whereas a 50% inhibition of cell growth was observed with a dose of 50 U/ml of IFN-beta ser. No significant growth inhibition was seen by rIFN-alpha A at doses up to 500 U/ml. Addition of rIFN-alpha A to rIFN-beta ser-treated EFC-2 cells neither suppressed nor augmented the antiproliferative response to IFN-beta ser. The binding of 125I-labeled rIFN-alpha A or 125I-labeled rIFN-beta ser to EFC-2 cells was inhibited competitively by increasing concentrations of either unlabeled rIFN-alpha A or rIFN-beta ser. This suggests that the cellular receptors for both rIFN-alpha A and rIFN-beta ser appear to be intact and appear to bind both agents equally. Furthermore, incubation of EFC-2 cells for 72 h with either rIFN-alpha A or rIFN-beta ser resulted in an increase in 2',5'-oligoadenylate (2-5A) synthetase activity 5-fold with rIFN-alpha A and 50-fold with rIFN-beta ser. Similarly, the 68-kD IFN-induced protein kinase was induced substantially with rIFN-beta ser but only slightly induced with rIFN-alpha A treatment. These results suggest that EFC-2 human glioma cells demonstrate a differential sensitivity in terms of growth inhibition to rIFN-beta ser and to rIFN-alpha A which appears to correlate with a differential induction of both intracellular 2-5A synthetase and protein kinase activity. These results cannot be explained solely on the basis of surface receptor binding of rIFN-alpha A and rIFN-beta ser. These data do suggest that, for human glioma cells in culture, type I IFN receptors may display a subtle architectural variation that allows equivalent binding of both IFN-alpha and IFN-beta ser, but allows an enhanced signal transduction and biological effect only after binding a specific IFN subtype." @default.
- W1970784535 created "2016-06-24" @default.
- W1970784535 creator A5045728929 @default.
- W1970784535 creator A5046338327 @default.
- W1970784535 creator A5048281793 @default.
- W1970784535 creator A5052687048 @default.
- W1970784535 creator A5056562780 @default.
- W1970784535 creator A5086744714 @default.
- W1970784535 date "1990-04-01" @default.
- W1970784535 modified "2023-09-25" @default.
- W1970784535 title "Growth Inhibitory Effects of Interferon-β but Not Interferon-α on Human Glioma Cells: Correlation of Receptor Binding, 2′,5′-O1igoadenylate Synthetase and Protein Kinase Activity" @default.
- W1970784535 cites W1558985378 @default.
- W1970784535 cites W1577005558 @default.
- W1970784535 cites W1932223319 @default.
- W1970784535 cites W1994736576 @default.
- W1970784535 cites W1999259276 @default.
- W1970784535 cites W2018670188 @default.
- W1970784535 cites W2018670987 @default.
- W1970784535 cites W2031211168 @default.
- W1970784535 cites W2045023213 @default.
- W1970784535 cites W2047377469 @default.
- W1970784535 cites W2051300254 @default.
- W1970784535 cites W2063975188 @default.
- W1970784535 cites W2070400974 @default.
- W1970784535 cites W2074656188 @default.
- W1970784535 cites W2080207655 @default.
- W1970784535 cites W2084160063 @default.
- W1970784535 cites W2088835194 @default.
- W1970784535 cites W2117164535 @default.
- W1970784535 cites W2146447599 @default.
- W1970784535 cites W2314309337 @default.
- W1970784535 doi "https://doi.org/10.1089/jir.1990.10.141" @default.
- W1970784535 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2140395" @default.
- W1970784535 hasPublicationYear "1990" @default.
- W1970784535 type Work @default.
- W1970784535 sameAs 1970784535 @default.
- W1970784535 citedByCount "62" @default.
- W1970784535 countsByYear W19707845352012 @default.
- W1970784535 countsByYear W19707845352013 @default.
- W1970784535 countsByYear W19707845352019 @default.
- W1970784535 countsByYear W19707845352020 @default.
- W1970784535 countsByYear W19707845352021 @default.
- W1970784535 countsByYear W19707845352023 @default.
- W1970784535 crossrefType "journal-article" @default.
- W1970784535 hasAuthorship W1970784535A5045728929 @default.
- W1970784535 hasAuthorship W1970784535A5046338327 @default.
- W1970784535 hasAuthorship W1970784535A5048281793 @default.
- W1970784535 hasAuthorship W1970784535A5052687048 @default.
- W1970784535 hasAuthorship W1970784535A5056562780 @default.
- W1970784535 hasAuthorship W1970784535A5086744714 @default.
- W1970784535 hasConcept C104317684 @default.
- W1970784535 hasConcept C126322002 @default.
- W1970784535 hasConcept C134018914 @default.
- W1970784535 hasConcept C153911025 @default.
- W1970784535 hasConcept C170493617 @default.
- W1970784535 hasConcept C199360897 @default.
- W1970784535 hasConcept C202751555 @default.
- W1970784535 hasConcept C203014093 @default.
- W1970784535 hasConcept C2776174256 @default.
- W1970784535 hasConcept C2776178377 @default.
- W1970784535 hasConcept C2779707156 @default.
- W1970784535 hasConcept C2781228144 @default.
- W1970784535 hasConcept C2909179924 @default.
- W1970784535 hasConcept C40767141 @default.
- W1970784535 hasConcept C41008148 @default.
- W1970784535 hasConcept C54355233 @default.
- W1970784535 hasConcept C55493867 @default.
- W1970784535 hasConcept C71924100 @default.
- W1970784535 hasConcept C81885089 @default.
- W1970784535 hasConcept C86803240 @default.
- W1970784535 hasConceptScore W1970784535C104317684 @default.
- W1970784535 hasConceptScore W1970784535C126322002 @default.
- W1970784535 hasConceptScore W1970784535C134018914 @default.
- W1970784535 hasConceptScore W1970784535C153911025 @default.
- W1970784535 hasConceptScore W1970784535C170493617 @default.
- W1970784535 hasConceptScore W1970784535C199360897 @default.
- W1970784535 hasConceptScore W1970784535C202751555 @default.
- W1970784535 hasConceptScore W1970784535C203014093 @default.
- W1970784535 hasConceptScore W1970784535C2776174256 @default.
- W1970784535 hasConceptScore W1970784535C2776178377 @default.
- W1970784535 hasConceptScore W1970784535C2779707156 @default.
- W1970784535 hasConceptScore W1970784535C2781228144 @default.
- W1970784535 hasConceptScore W1970784535C2909179924 @default.
- W1970784535 hasConceptScore W1970784535C40767141 @default.
- W1970784535 hasConceptScore W1970784535C41008148 @default.
- W1970784535 hasConceptScore W1970784535C54355233 @default.
- W1970784535 hasConceptScore W1970784535C55493867 @default.
- W1970784535 hasConceptScore W1970784535C71924100 @default.
- W1970784535 hasConceptScore W1970784535C81885089 @default.
- W1970784535 hasConceptScore W1970784535C86803240 @default.
- W1970784535 hasIssue "2" @default.
- W1970784535 hasLocation W19707845351 @default.
- W1970784535 hasLocation W19707845352 @default.
- W1970784535 hasOpenAccess W1970784535 @default.
- W1970784535 hasPrimaryLocation W19707845351 @default.
- W1970784535 hasRelatedWork W1005646979 @default.
- W1970784535 hasRelatedWork W1901616315 @default.
- W1970784535 hasRelatedWork W1987001477 @default.